Publications

Effects of the selective heart rate-reducing agent ivabradine on the time to onset of ventricular fibrillation during myocardial ischaemia in pigs: comparison with the beta-blocker propranolol

Publié en janvier 2010 FUNDAMENTAL & CLINICAL PHARMACOLOGY
janvier 2010

Role of posttranslational modification of CD36 in cardiac fatty acid utilization: lessons from the spontaneously hypertensive rat

FUNDAMENTAL & CLINICAL PHARMACOLOGY
Publication précédente
janvier 2010

Ivabradine reduces heart rate without affecting metabolic fluxes of normoxic working hearts

FUNDAMENTAL & CLINICAL PHARMACOLOGY
Publication suivante

Auteurs